期刊文献+

IgA肾病血脂异常与临床病理分析 被引量:6

Analysis on clinicopathological features and dyslipidemia in IgA nephropathy
下载PDF
导出
摘要 目的探讨血脂异常与IgA肾病临床及病理的关系。方法收集自2008年1月至2015年11月肾活检诊断为IgA肾病患者178例。分别使用Lee氏分级及牛津分级对IgA肾病患者进行病理分级。分别探讨血脂异常、高三酰甘油血症、高胆固醇血症与IgA肾病临床及病理之间的关系。结果 IgA肾病伴血脂异常尤其是伴高三酰甘油血症者,24h尿蛋白定量升高,有较高的血肌酐和较低的eGFR。IgA肾病伴血脂异常尤其是伴高三酰甘油血症者,肾小管萎缩和(或)间质纤维化者比例高(58.5%)。结论应加强对IgA肾病患者血脂异常的认识,积极地降脂治疗,延缓IgA肾病的进展。 Objective To explore the relationship between dyslipidemia with clinic and pathological features in lgA nephrop- athy. Methods A total of 178 IgA nephropathy diagnosed by biopsy from January 2008 to November 2015 were collected. Accord- ing to Lee's classification and Oxford classification;these patients were performed the pathological grades of IgA nephropathy. The relationship among dyslipidemia, hypertriglyceridemia, hypercholesterolemia and the clinical and pathological features of IgA ne- phropathy was respectively investigated. Results The patients with IgA nephropathy complicating dyslipidemia, particularly hyper- triglyceridemia, had higher 24-h urine protein,higher serum creatinine and lower eGFR. The patients with IgA nephropathy compli- cating dyslipidemia, especially hypertriglyceridemia; had the higher proportion of renal tubular atrophy and/or interstitial fibrosis (58.5 %). Conclusion The understanding of dyslipidemia in the patients with IgA nephropathy should be strengthened, lipid-low- ering treatment should be actively conducted to delay the progress of IgA nephropathy.
出处 《重庆医学》 CAS 北大核心 2016年第32期4511-4513,4516,共4页 Chongqing medicine
基金 顺德区卫生和计划生育局医学科研立项课题(2015B009)
关键词 IGA肾病 血脂异常 高三酰甘油血症 高胆固醇血症 IgA nephropathy dyslipidemia hypertriglyeeridemia hypercholesterolemia
  • 相关文献

参考文献3

二级参考文献21

  • 1朱文华,陈蕾倩,方力争,钱贞英,陈彦.高尿酸血症与血脂、肥胖相关因素分析[J].浙江预防医学,2004,16(12):70-70. 被引量:33
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5223
  • 3Coppo R,D'Amico G.Factors predicting progression of IgA nephropathies[J].J Nephrol,2005,18(5):503 - 512.
  • 4Syrj-tnen J,Mustonen J,Pasternack A.Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy[J].Nephrol Dial Transplant,2000,15(1): 34 - 42.
  • 5Katafuchi R,Kiyoshi Y, Oh Y, et al.Glomerular score as a prognosticator in IgA nephropathy:its usefulness and limitation[J]. Clin Nephrol, 1998,49(1 ): 1 - 8.
  • 6Abrass CK.Cellular lipid metabolism and the role of lipids in progressive renal disease[J].Am J Nephrol,2004,24(1): 46 - 53.
  • 7Spencer MW, Muhlfeld AS,Segerer S,et al.Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice[J].Am J Nephrol,2004,24(1):20 - 31.
  • 8Iwasa Y, Otsubo S,Ishizuka T, et al.Influence of serum high-molecular-weight and total adiponectin on arteriosclerosis in IgA nephropathy patients[J].Nephron Clin Pract,2008,108(3):c226 - c232.
  • 9Rauta V, Finne P, Fagerudd J,et al.Factors associated with progression of IgA nephropathy are related to renal function a model for estimating risk of progression in mild disease[J]. Clin Nephrol,2002,58(2):85 - 94.
  • 10Nakamura T,Ushiyama C,Hirokawa K,et al.Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis[J].Nephrol Dial Transplant,2002,17(5):798 - 802.

共引文献116

同被引文献52

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部